A Prospective, Single center, Single-Arm Clinical Study of 13-20 participants who are seeking a procedure to reduce the appearance of the peri-orbital wrinkles, and meet study eligibility criteria, and have provided informed consent will be enrolled in the study. Each study participate will receive up to 4 treatments with Tixel in monthly interval. Follow-up will occur at 1 month and 3 months following the last visit.~The clinic visits will be as follow:~Base line (1st tx)~Phone-call visit (3 days after the first treatment)~4 week (2nd tx)~8 week (3rd tx)~12 week (4th tx)~4 weeks after the last treatment (1st Follow-up)~12 weeks after the last treatment (2nd follow-up = 3 months follow-up, primary endpoint and the study completion visit)~Primary Safety Endpoint is the evaluation of related adverse events up to the 3-month visit after treatment.
A Prospective, Single center, Single-Arm Clinical Study of 13-20 study participants who are seeking a procedure to reduce the appearance of the peri-orbital wrinkles. Each study participant will receive up to four (4) treatments with the Tixel in a monthly interval. Follow-up will occur 1 month and 3 months following last treatment.